JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online October 17, 2007
J Nucl Med 2007, doi:10.2967/jnumed.107.044362
© 2007 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.107.044362v1
48/11/1761    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hellwig, D.
Right arrow Articles by Kirsch, C.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hellwig, D.
Right arrow Articles by Kirsch, C.-M.


18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?

Dirk Hellwig 1*, Thomas P. Graeter 2, Dieter Ukena 3, Andreas Groeschel 4, Gerhard W. Sybrecht 4, Hans-Joachim Schaefers 5, and Carl-Martin Kirsch 1

1 Department of Nuclear Medicine, Saarland University Medical Center, Homburg/Saar, Germany
2 Department of Cardiovascular and Thoracic Surgery, Saarland University Medical Center, Homburg/Saar, Germany; Department of Thoracic and Vascular Surgery, Klinik Löwenstein, Löwenstein, Germany
3 Department of Internal Medicine V (Pneumology), Saarland University Medical Center, Homburg/Saar, Germany; Department of Pneumology, Klinikum Bremen-Ost, Bremen, Germany
4 Department of Internal Medicine V (Pneumology), Saarland University Medical Center, Homburg/Saar, Germany
5 Department of Cardiovascular and Thoracic Surgery, Saarland University Medical Center, Homburg/Saar, Germany

* To whom correspondence should be addressed. E-mail: Dirk.Hellwig{at}uks.eu.


   Abstract

18F-FDG PET is the most accurate noninvasive modality for staging mediastinal lymph nodes in lung cancer. Besides using visual image interpretation, some institutions use standardized uptake value (SUV) measurements in lymph nodes. Mostly, an SUV of 2.5 is used as the cutoff, but this choice was never deduced from respective studies. Receiver operating characteristic (ROC) analyses demonstrated that SUV thresholds of more than 4 resulted in the highest accuracy. But these high cutoffs imply high false-negative rates (FNRs). The aim of our evaluation was to determine an optimal SUV threshold and to compare its diagnostic performance with the results of visual interpretation. Methods: This retrospective study included 95 patients with suspected lung cancer who underwent mediastinoscopy/mediastinal lymphadenectomy after 18F-FDG PET (90–150 min after 250 MBq of 18F-FDG). Maximum SUV was measured in 371 lymph node regions biopsied afterward and visually interpreted using a 6-level score (- - - through + + +). Diagnostic performance was assessed by ROC analysis. FNR and false-positive rate (FPR), the sum of both error rates (FNR + FPR), and diagnostic accuracy were plotted against a hypothetical SUV threshold to determine the optimum SUV threshold. Results: SUVs in metastatic lymph nodes were higher (mean ± SD, 7.1 ± 4.5; range, 1.4–26.9; n = 70) than in tumor-free lymph node stations (2.4 ± 1.7; range, 0.6–14.9; n = 301; P < 0.01). Inflammatory lymph nodes exhibited slightly increased SUVs (2.7 ± 2.0; range, 0.8–14.9; n = 146). The plot of error rates featured a minimum of the sum FNR + FPR for an SUV of 2.5. With increasing SUV threshold, the FPR decreased most prominently up to that value whereas a continuous rise of FNR was noticed. Highest diagnostic accuracy was achieved with an SUV of 4.5. The areas under the ROC curves demonstrated that visual interpretation tends to be more accurate than SUV quantification (visual, 0.930 ± 0.022; SUV, 0.899 ± 0.025; P = 0.241). Using an SUV of 2.5 as the threshold, the resulting sensitivity, specificity, and negative predictive value were 89%, 84%, and 96%, respectively. Conclusion: For mediastinal staging, the choice of an SUV of 2.5 as the threshold is justified because FNR + FPR is minimized. The resulting high negative predictive value of 96% allows the omission of mediastinoscopy in patients with negative mediastinal findings on 18F-FDG PET images. For the experienced observer, visual analysis should be relied on primarily, with calculation of the SUV used, at most, as a secondary aid. For the less experienced observer, the SUV may be of greater value.

Key Words: positron emission tomography, lung neoplasms, mediastinal staging, 18F-fluorodeoxyglucose




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
M. Imbriaco, M. G. Caprio, G. Limite, L. Pace, T. De Falco, E. Capuano, and M. Salvatore
Dual-Time-Point 18F-FDG PET/CT Versus Dynamic Breast MRI of Suspicious Breast Lesions
Am. J. Roentgenol., November 1, 2008; 191(5): 1323 - 1330.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.